Prostate cancer

References

• American Cancer Society. Cancer facts and figures, 1992. Atlanta: American Cancer Society, 1992
   Google Scholar
• Meikle AW, Smith JA Jr. Epidemiology of prostate cancer. Urol Clin North Am 1990: 17(4): 709–18
   PubMed Web of Science ®Google Scholar
• Smith PH. The case for no initial treatment of localized prostate cancer. Urol Clin North Am 1990: 17(4): 827–34
   PubMed Web of Science ®Google Scholar
• Friedland GW, Chang P. The role of imaging in prostate cancer. Radiol Clin North Am 1991: 29(3): 581–9
   PubMed Web of Science ®Google Scholar
• Bostwick DG. The pathology of early prostate cancer. CA 1989: 39(6): 376–93
   Google Scholar
• Johansson JE, Adami HO, Andersson SO, et al. Natural history of localised prostatic cancer: a population-based study in 223 untreated patients. Lancet 1989: 1(8642): 799–803
   PubMed Web of Science ®Google Scholar
• Nativ O, Winkler HZ, Raz Y, et al. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. Mayo Clin Proc 1989: 64(8): 911–9
   PubMed Web of Science ®Google Scholar
• Newling DW, Estrada Arras C, Bono A. History and physical examination in prostate cancer: which information is essential in diagnosis and follow-up? Prog Clin Biol Res 1990: 357: 151–6
   PubMedGoogle Scholar
• Lee F, Torp-Pedersen ST, Siders DB. Use of transrectal ultrasound in diagnosis, guided biopsy, staging, and screening of prostate cancer. Urology 1989: 33(6 Suppl): 7–12
   PubMed Web of Science ®Google Scholar
• Wilson TM, Guthman DA. Current status of transrectal ultrasonography in the detection of prostate cancer. Oncology (Williston Park) 1991: 5(1): 73–8
   PubMedGoogle Scholar
• Mettlin C, Dodd GD. The American Cancer Society guidelines for the cancer-related checkup: an update. CA 1991: 41(5): 279–99
   Google Scholar
• Gerber GS, Chodak GW. Digital rectal examination in the early detection of prostate cancer. Urol Clin North Am 1990: 17(4): 739–44
   PubMed Web of Science ®Google Scholar
• Lee F, Torp-Pedersen S, Littrup PJ, et al. Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen. Radiology 1989: 170(1 Pt 1): 29–32
   PubMed Web of Science ®Google Scholar
• Scher H. Prostatic cancer: where do we go from here? Curr Opin Oncol 1991: 3(3): 568–74
   PubMedGoogle Scholar
• Thompson IM, Fair WR. Screening for carcinoma of the prostate: efficacy of available screening tests. World J Surg 1989: 13(1): 65–70
   PubMed Web of Science ®Google Scholar
• Hinman F Jr. Screening for prostatic carcinoma. J Urol 1991: 145(1): 126–30
   PubMed Web of Science ®Google Scholar
• Gerber GS, Chodak GW. Routine screening for cancer of the prostate. J Nad Cancer Inst 1991: 83(5): 329–35
   PubMedGoogle Scholar
• Cooper EH. Tumour markers in prostatic cancer. Scand J Clin Lab Invest Suppl 1991: 206: 42–51
   PubMedGoogle Scholar
• Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991: 145(5): 907–23
   PubMed Web of Science ®Google Scholar
• Drago JR, Nesbitt JA, Badalament RA, et al. Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate: Ohio State University experience. Urology 1989: 34(4): 187–92
   PubMed Web of Science ®Google Scholar
• Frame PS. A critical review of adult health maintenance. Part 3: Prevention of cancer. J Fam Pract 1986: 22(6): 511–20
   PubMed Web of Science ®Google Scholar
• Optenberg SA, Thompson IM. Economics of screening for carcinoma of the prostate. Urol Clin North Am 1990: 17(4): 719–37
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task Force. Guide to clinical preventive services: an assessment of the effectiveness of 169 interventions. Baltimore: Williams & Wilkins, 1989: 63–6
   Google Scholar
• Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol 1989: 142 (Jul): 66–70
   PubMed Web of Science ®Google Scholar
• Scardino PT. Transrectal ultrasound in management of prostate cancer. Urology 1989: 33(6 Suppl): 27–31
   PubMed Web of Science ®Google Scholar
• Andriole GL, Coplen DE, Mikkelsen DJ, et al. Sonographic and pathological staging of patients with clinically localized prostate cancer. J Urol 1989: 142(Nov): 1259–61
   PubMed Web of Science ®Google Scholar
• Gervasi LA, Mata J, Easley JD, et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 1989: 142(Aug): 332–6
   PubMed Web of Science ®Google Scholar
• Asbell SO, Martz KL, Pilepich MV, et al. Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG Phase III study for A2 and B prostate carcinoma. Int J Radiat Oncol Biol Phys 1989: 17(5): 945–51
   PubMed Web of Science ®Google Scholar
• Leroy M, Teillac P, Rain JD, et al. Radioimmunodetection of lymph node invasion in prostatic cancer: the use of iodine 123 (123I)-labeled monoclonal anti-prostatic acid phos-phatase (PAP) 227 A F(ab')2 antibody fragments in vivo. Cancer 1989: 64(1): 1–5
   PubMed Web of Science ®Google Scholar
• Piccoli CW Rifldn MD. Magnetic resonance imaging of the prostate and bladder. Top Magn Reson Imaging 1990: 2(3): 51–66
   PubMedGoogle Scholar
• Thompson IM, Zeidman EJ, Rodriguez FR. Sudden death due to disease flare with luteinizing hormone-releasing hormone agonist therapy for carcinoma of the prostate. J Urol 1990: 144(Dec): 1479–80
   PubMed Web of Science ®Google Scholar
• Henriksson P, Edhag O, Eriksson A, et al. Patients at high risk of cardiovascular complications in oestrogen treatment of prostatic cancer. Br J Urol 1989: 63(2): 186–90
   PubMedGoogle Scholar
• Rosenman J, Chaney EL, Sailer S, et al. Recent advances in radiotherapy treatment planning. Cancer Invest 1991: 9(4): 465–81
   PubMed Web of Science ®Google Scholar
• Shevlin BE, Mittal BB, Brand WN. et al. The role of adjuvant irradiation following primary prostatectomy, based on histopathologic extent of tumor. Int J Radiat Oncol Biol Phys 1989: 16(6): 1425–30
   PubMed Web of Science ®Google Scholar
• Kuban DA, el-Mahdi AM, Schellhammer PF. 1–125 interstitial implantation for prostate cancer: what have we learned 10 years later? Cancer 1989: 63(12): 2415–20
   PubMed Web of Science ®Google Scholar
• Warner JA, Heston WD. Future developments of nonhormonal systemic therapy for prostatic carcinoma. Urol Clin North Am 1991: 18(1): 25–33
   PubMed Web of Science ®Google Scholar
• Lange PH, Ercole CJ, Lightner DJ, et al. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989: 141 (Apr): 873–9
   PubMed Web of Science ®Google Scholar
• Kabalin JN, Hodge KK, McNeal JE, et al. Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen. J Urol 1989: 142(Aug): 326–31
   PubMed Web of Science ®Google Scholar